Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	488.4	634.36	794.07	2,531	2,541	434.69
Trading Asset Securities	1,555	1,429	1,579	-	-	100
Cash & Short-Term Investments	2,043	2,063	2,373	2,531	2,541	534.69
Cash Growth	1.03%	-13.06%	-6.23%	-0.41%	375.27%	66.97%
Accounts Receivable	457.55	522.56	452.08	346.13	396.47	337.99
Other Receivables	1.65	1.42	1.2	100.23	74.77	57.66
Receivables	459.2	523.98	453.28	446.37	471.24	395.65
Inventory	426.08	412.66	347.56	307.42	339.1	324
Other Current Assets	42.84	52.7	27.26	44.14	20.79	25.08
Total Current Assets	2,972	3,053	3,201	3,329	3,372	1,279
Property, Plant & Equipment	1,681	1,690	1,426	983.41	779.77	721.73
Other Intangible Assets	133.67	139.79	139.21	150.2	142.61	144.24
Long-Term Deferred Tax Assets	5.12	4.39	3.31	2.81	4.72	4.39
Long-Term Deferred Charges	8.81	13	21.82	22.92	17.65	0.33
Other Long-Term Assets	9.28	24.37	25.34	59.71	4.86	3.08
Total Assets	4,809	4,924	4,817	4,548	4,322	2,153

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	280.6	258.49	286.76	132.18	143.51	129.77
Accrued Expenses	120.93	643.22	676.84	607.02	598.17	472.26
Short-Term Debt	-	-	40.03	55.05	40.05	70.09
Current Portion of Long-Term Debt	10.98	-	-	4.95	4.95	7.01
Current Portion of Leases	-	16.76	14.33	19.66	16.26	10.56
Current Income Taxes Payable	23	10.85	25.83	19.29	39.65	17.34
Current Unearned Revenue	66.41	23.88	36.59	39.74	80.96	42.82
Other Current Liabilities	479.13	98.1	109.55	120.48	129.46	116.64
Total Current Liabilities	981.05	1,051	1,190	998.38	1,053	866.48
Long-Term Debt	-	-	-	12.37	17.33	7.28
Long-Term Leases	6.64	9	20.79	32.26	44.33	43.06
Long-Term Unearned Revenue	51.16	49.06	34.49	10.02	9.5	4.14
Long-Term Deferred Tax Liabilities	24.04	21.79	15.33	18.22	18.85	16.9
Total Liabilities	1,063	1,131	1,261	1,071	1,143	937.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	480	480	480	480	480	360
Additional Paid-In Capital	1,662	1,662	1,662	1,662	1,662	146.47
Retained Earnings	1,755	1,803	1,567	1,314	1,017	686.08
Treasury Stock	-176.19	-176.19	-176.19	-	-	-
Comprehensive Income & Other	10.27	10.39	10.98	12.34	15.1	18.94
Total Common Equity	3,731	3,779	3,545	3,468	3,174	1,211
Minority Interest	14.94	13.42	11.53	8.12	4.55	3.83
Shareholders' Equity	3,746	3,793	3,556	3,477	3,179	1,215
Total Liabilities & Equity	4,809	4,924	4,817	4,548	4,322	2,153

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.63	25.76	75.16	124.3	122.92	137.99
Net Cash (Debt)	2,026	2,037	2,298	2,407	2,418	396.7
Net Cash Growth	1.79%	-11.34%	-4.51%	-0.49%	509.62%	67.76%
Net Cash Per Share	4.38	4.34	4.89	5.02	5.73	1.10
Filing Date Shares Outstanding	453.92	468	468	480	480	360
Total Common Shares Outstanding	453.92	468	468	480	480	360
Working Capital	1,990	2,001	2,011	2,330	2,319	412.94
Book Value Per Share	8.22	8.08	7.57	7.23	6.61	3.37
Tangible Book Value	3,598	3,640	3,405	3,318	3,032	1,067
Tangible Book Value Per Share	7.93	7.78	7.28	6.91	6.32	2.96
Buildings	-	1,288	523.07	520.3	506.03	443.93
Machinery	-	911.52	609.64	558.75	511.19	416.4
Construction In Progress	-	19.27	719.15	255.66	46.72	100.06

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error